These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 37257024)

  • 1. Aurones: A Promising Scaffold to Inhibit SARS-CoV-2 Replication.
    Caleffi GS; Rosa AS; de Souza LG; Avelar JLS; Nascimento SMR; de Almeida VM; Tucci AR; Ferreira VN; da Silva AJM; Santos-Filho OA; Miranda MD; Costa PRR
    J Nat Prod; 2023 Jun; 86(6):1536-1549. PubMed ID: 37257024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flavonoids in Ampelopsis grossedentata as covalent inhibitors of SARS-CoV-2 3CL
    Xiong Y; Zhu GH; Zhang YN; Hu Q; Wang HN; Yu HN; Qin XY; Guan XQ; Xiang YW; Tang H; Ge GB
    Int J Biol Macromol; 2021 Sep; 187():976-987. PubMed ID: 34333006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Commercially Available Flavonols Are Better SARS-CoV-2 Inhibitors than Isoflavone and Flavones.
    Chaves OA; Fintelman-Rodrigues N; Wang X; Sacramento CQ; Temerozo JR; Ferreira AC; Mattos M; Pereira-Dutra F; Bozza PT; Castro-Faria-Neto HC; Russo JJ; Ju J; Souza TML
    Viruses; 2022 Jun; 14(7):. PubMed ID: 35891437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Darunavir Derivatives for Inhibition of SARS-CoV-2 3CL
    Ma L; Xie Y; Zhu M; Yi D; Zhao J; Guo S; Zhang Y; Wang J; Li Q; Wang Y; Cen S
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-guided design of direct-acting antivirals that exploit the gem-dimethyl effect and potently inhibit 3CL proteases of severe acute respiratory syndrome Coronavirus-2 (SARS-CoV-2) and middle east respiratory syndrome coronavirus (MERS-CoV).
    Dampalla CS; Miller MJ; Kim Y; Zabiegala A; Nguyen HN; Madden TK; Thurman HA; Machen AJ; Cooper A; Liu L; Battaile KP; Lovell S; Chang KO; Groutas WC
    Eur J Med Chem; 2023 Jun; 254():115376. PubMed ID: 37080108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and synthesis of isatin derivatives as effective SARS-CoV-2 3CL protease inhibitors.
    Bao HL; Tu G; Yue Q; Liu P; Zheng HL; Yao XJ
    Chem Biol Drug Des; 2023 Oct; 102(4):857-869. PubMed ID: 37563791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural Polyphenols Inhibit the Dimerization of the SARS-CoV-2 Main Protease: The Case of Fortunellin and Its Structural Analogs.
    Panagiotopoulos AA; Karakasiliotis I; Kotzampasi DM; Dimitriou M; Sourvinos G; Kampa M; Pirintsos S; Castanas E; Daskalakis V
    Molecules; 2021 Oct; 26(19):. PubMed ID: 34641612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chloropyridinyl Esters of Nonsteroidal Anti-Inflammatory Agents and Related Derivatives as Potent SARS-CoV-2 3CL Protease Inhibitors.
    Ghosh AK; Shahabi D; Yadav M; Kovela S; Anson BJ; Lendy EK; Bonham C; Sirohi D; Brito-Sierra CA; Hattori SI; Kuhn R; Mitsuya H; Mesecar AD
    Molecules; 2021 Sep; 26(19):. PubMed ID: 34641337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-Based Discovery of Novel Nonpeptide Inhibitors Targeting SARS-CoV-2 M
    Yang J; Lin X; Xing N; Zhang Z; Zhang H; Wu H; Xue W
    J Chem Inf Model; 2021 Aug; 61(8):3917-3926. PubMed ID: 34279924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery and Crystallographic Studies of Nonpeptidic Piperazine Derivatives as Covalent SARS-CoV-2 Main Protease Inhibitors.
    Gao S; Song L; Claff T; Woodson M; Sylvester K; Jing L; Weiße RH; Cheng Y; Sträter N; Schäkel L; Gütschow M; Ye B; Yang M; Zhang T; Kang D; Toth K; Tavis J; Tollefson AE; Müller CE; Zhan P; Liu X
    J Med Chem; 2022 Dec; 65(24):16902-16917. PubMed ID: 36475694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a Cell-Based Luciferase Complementation Assay for Identification of SARS-CoV-2 3CL
    Rawson JMO; Duchon A; Nikolaitchik OA; Pathak VK; Hu WS
    Viruses; 2021 Jan; 13(2):. PubMed ID: 33498923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polyphenolic Compounds Isolated from Marine Algae Attenuate the Replication of SARS-CoV-2 in the Host Cell through a Multi-Target Approach of 3CL
    Nagahawatta DP; Liyanage NM; Je JG; Jayawardhana HHACK; Jayawardena TU; Jeong SH; Kwon HJ; Choi CS; Jeon YJ
    Mar Drugs; 2022 Dec; 20(12):. PubMed ID: 36547933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenylbenzopyrone of Flavonoids as a Potential Scaffold to Prevent SARSCoV-2 Replication by Inhibiting its M
    Potshangbam AM; Nongdam P; Kumar AK; Rathore RS
    Curr Pharm Biotechnol; 2021; 22(15):2054-2070. PubMed ID: 33504301
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Sharma A; Goyal S; Yadav AK; Kumar P; Gupta L
    J Biomol Struct Dyn; 2022 Jan; 40(1):86-100. PubMed ID: 32896226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthetic flavonoids as potential antiviral agents against SARS-CoV-2 main protease.
    Batool F; Mughal EU; Zia K; Sadiq A; Naeem N; Javid A; Ul-Haq Z; Saeed M
    J Biomol Struct Dyn; 2022 May; 40(8):3777-3788. PubMed ID: 33251983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Promising Sulfonamide Chalcones as Inhibitors of SARS-CoV-2 3CL
    Pojtanadithee P; Hengphasatporn K; Suroengrit A; Boonyasuppayakorn S; Wilasluck P; Deetanya P; Wangkanont K; Sukanadi IP; Chavasiri W; Wolschann P; Langer T; Shigeta Y; Maitarad P; Sanachai K; Rungrotmongkol T
    J Chem Inf Model; 2023 Aug; 63(16):5244-5258. PubMed ID: 37581276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and Biochemical Evaluation of 8
    Wu J; Feng B; Gao LX; Zhang C; Li J; Xiang DJ; Zang Y; Wang WL
    Molecules; 2022 May; 27(10):. PubMed ID: 35630836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of Dihydrobenzofuro[3,2-b]chromenes as Potential 3CLpro Inhibitors of SARS-CoV-2: A Molecular Docking and Molecular Dynamics Study.
    Gorai S; Junghare V; Kundu K; Gharui S; Kumar M; Patro BS; Nayak SK; Hazra S; Mula S
    ChemMedChem; 2022 Apr; 17(8):e202100782. PubMed ID: 35112482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virtual high throughput screening: Potential inhibitors for SARS-CoV-2 PL
    Jade D; Ayyamperumal S; Tallapaneni V; Joghee Nanjan CM; Barge S; Mohan S; Nanjan MJ
    Eur J Pharmacol; 2021 Jun; 901():174082. PubMed ID: 33823185
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Liu H; Ye F; Sun Q; Liang H; Li C; Li S; Lu R; Huang B; Tan W; Lai L
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):497-503. PubMed ID: 33491508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.